Brief: Regeneus To Be Granted Key Progenza Patent In Europe

Cambium Bio

16/03/2021 01:52

March 16 (Reuters) - Regeneus Ltd  RGS.AX :
    * REGENEUS TO BE GRANTED KEY PROGENZA PATENT IN
EUROPE-RGS.AX
    * PATENT GIVES REGENEUS PROTECTION FOR PROGENZA™ FOR
TREATMENT OF
PAIN IN EUROPE THROUGH TO 2032

Source text for Eikon:  ID:nASX7V8P9w 
Further company coverage:  RGS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))